Description of Sign-and-symptom Associations at Acromegaly Diagnosis.
ACRO-POLIS
1 other identifier
observational
648
1 country
25
Brief Summary
The purpose of this study is to describe most characteristic association of signs and symptoms present at the time of acromegaly diagnosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2013
Shorter than P25 for all trials
25 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2013
CompletedFirst Submitted
Initial submission to the registry
November 28, 2013
CompletedFirst Posted
Study publicly available on registry
December 16, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2014
CompletedAugust 5, 2019
August 1, 2019
9 months
November 28, 2013
August 1, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Description of the most characteristic sign-and-symptom associations of acromegaly, collected by a patient questionnaire.
At the time of patient diagnosis, up to 3 months
Secondary Outcomes (1)
Description of demographic and clinical characteristics of patients with acromegaly, collected by a patient questionnaire.
At the time of patient diagnosis, up to 3 months
Study Arms (1)
Acromegalic patients
Eligibility Criteria
Acromegalic patients
You may qualify if:
- Adult patient (greater than or equal to 18 years old)
- Patient with acromegaly, diagnosed for less than 5 years
You may not qualify if:
- Patient who have objected to the collection of his/her data
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ipsenlead
Study Sites (25)
Hôpital Sud
Amiens, France
CHU Besançon Hôpital Jean Minjoz
Besançon, France
Hôpital la Cavale Blanche
Brest, France
Chu Cote de Nacre
Caen, France
Hôpital Henri Mondor
Créteil, France
Chu de Grenoble Hôpital Albert Michallon
Grenoble, France
Hôpital Claude Huriez
Lille, France
Hôpital le Cluzeau
Limoges, France
Hôpital Neuro-cardiologique
Lyon, France
Hôpital de la Timone
Marseille, France
Hôpital Lepeyronie
Montpellier, France
Hôpitaux de Brabois
Nancy, France
CHR Orléans - Hôpital la Source
Orléans, France
CH de Bicetre
Paris, France
CH Pitie Salpetreire
Paris, France
Hôpital Lariboisiere
Paris, France
Hôpital Haut Leveque
Pessac, France
CHU Reims - Hôpital Robert Debre
Reims, France
Hôpital Sud Anne de Bretagne
Rennes, France
CHU Rouen - Hôpital de Bois Guillaume
Rouen, France
Hôptital Nord
Saint-Etienne, France
Hôpital Civil
Strasbourg, France
Hôpital de Hautepierre
Strasbourg, France
Hôpital Larrey
Toulouse, France
CHU Bretonneau
Tours, France
Related Publications (1)
Caron P, Brue T, Raverot G, Tabarin A, Cailleux A, Delemer B, Renoult PP, Houchard A, Elaraki F, Chanson P. Signs and symptoms of acromegaly at diagnosis: the physician's and the patient's perspectives in the ACRO-POLIS study. Endocrine. 2019 Jan;63(1):120-129. doi: 10.1007/s12020-018-1764-4. Epub 2018 Sep 29.
PMID: 30269264DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Ipsen Medical Director
Ipsen
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 28, 2013
First Posted
December 16, 2013
Study Start
September 1, 2013
Primary Completion
June 1, 2014
Study Completion
June 1, 2014
Last Updated
August 5, 2019
Record last verified: 2019-08